Get started
Author

Sinata Koulla‐Shiro

Observed names: Koulla Shiro Sinata, Koulla Shiro, Sinata, Koulla-Shiro S, Koulla-Shiro Sinata, Koulla-Shiro, Sinata, S Koulla-Shiro, S Koulla‐Shiro, S. Koulla-Shiro, SInata Koulla-Shiro, Shiro Koulla Sinata, Sinata Koulla, Sinata Koulla Shiro, Sinata Koulla-Shiro, Sinata Koulla-Shiro (375648), Sinata Koulla-shiro, Sinata S Koulla
Observed institutions: Intersil (United States), Université de Yaoundé I, University of Buea, Inserm, Université de Montpellier, Aix-Marseille Université, Centre Hospitalier Universitaire de Montpellier, Central Hospital of Yaoundé, Centre Pasteur du Cameroun, Agence Nationale de Recherches sur le Sida et les Hépatites Virales, Ministry of Public Health, Catholic University of Central Africa, Institute of Parasitology, National Center of Infectious and Parasitic Diseases, Institut de Recherche pour le Développement, Université Montpellier 1
OpenAlex ID: A5058617930
Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial
2004 · Christian Laurent, Charles Kouanfack, et al. · The Lancet · 309
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon
2020 · Alexandra Calmy, Tamara Tovar Sanchez, et al. · The Lancet HIV · 161
Prevalence of methicillin—resistant Staphylococcus aureus in eight African hospitals and Malta
2003 · C. Kesah, S. Ben Redjeb, et al. · Clinical Microbiology and Infection · 160
Effect of mobile phone reminders on follow-up medical care of children exposed to or infected with HIV in Cameroon (MORE CARE): a multicentre, single-blind, factorial, randomised controlled trial
2014 · Jean Joel R Bigna, Jean Jacques N Noubiap, et al. · The Lancet Infectious Diseases · 108
Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial
2011 · Christian Laurent, Charles Kouanfack, et al. · The Lancet Infectious Diseases · 94
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries
2018 · Angela Loyse, Jessica Burry, et al. · The Lancet Infectious Diseases · 90
Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon
2009 · Sylvie Boyer, Fred Eboko, et al. · AIDS · 85
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial
2017 · Laura Ciaffi, Sinata Koulla-Shiro, et al. · The Lancet HIV · 77
Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Yaounde, Cameroon
2005 · Joseph Gangoué-Piéboji, Branka Bedenic, et al. · Journal of Clinical Microbiology · 67
Low Levels of Antiretroviral‐Resistant HIV Infection in a Routine Clinic in Cameroon that Uses the World Health Organization (WHO) Public Health Approach to Monitor Antiretroviral Treatment and Adequacy with the WHO Recommendation for Second‐Line Treatment
2009 · Charles Kouanfack, Celine Montavon, et al. · Clinical Infectious Diseases · 66
PDF
Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12‐116)
2008 · Fabienne Marcellin, Sylvie Boyer, et al. · Tropical Medicine & International Health · 65
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
2016 · Jean Joel R. Bigna, Claudia S. Plottel, et al. · Infectious Diseases of Poverty · 62
PDF
Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test
2018 · Elvis Temfack, Charles Kouanfack, et al. · Frontiers in Microbiology · 56
PDF
Bacterial Etiology and Antibiotic Resistance Profile of Community-Acquired Urinary Tract Infections in a Cameroonian City
2016 · Rolf Nyah-tuku Nzalie, Hortense Kamga Gonsu, et al. · International Journal of Microbiology · 56
PDF
Factors Associated with Death during Tuberculosis Treatment of Patients Co-Infected with HIV at the Yaoundé Central Hospital, Cameroon: An 8-Year Hospital-Based Retrospective Cohort Study (2006–2013)
2014 · Ako A. Agbor, Jean Joel R. Bigna, et al. · PLoS ONE · 51
PDF
Human Immunodeficiency Virus Infection and Associated Factors among Specific Population Subgroups in Cameroon
2007 · Jembia J. Mosoko, Isaac B. Macauley, et al. · AIDS and Behavior · 50
Mortality, AIDS-Morbidity, and Loss to Follow-up by Current CD4 Cell Count Among HIV-1–Infected Adults Receiving Antiretroviral Therapy in Africa and Asia
2012 · Delphine Gabillard, Charlotte Lewden, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 49
PDF
Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon
2004 · Joseph Gangoué Piéboji, Sinata Koulla-Shiro, et al. · International Journal of Infectious Diseases · 49
Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon
2015 · Charlotte Boullé, Charles Kouanfack, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 48
Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis
2013 · Sylvie Boyer, Laura March, et al. · The Lancet Infectious Diseases · 45
Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study.
2012 · Henry Namme Luma, Marie-Solange Doualla, et al. · PubMed · 45
Performance of HIV care decentralization from the patient's perspective: health-related quality of life and perceived quality of services in Cameroon
2011 · S. Boyer, C. Protopopescu, et al. · Health Policy and Planning · 45
PDF
The in-vitro antimicrobial activity of some medicinal plants against β-lactam-resistant bacteria
2009 · Joseph Gangoue-Pieboji, Noelly Eze, et al. · The Journal of Infection in Developing Countries · 45
PDF
Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa
2015 · Laura Ciaffi, Sinata Koulla-Shiro, et al. · AIDS · 44
Antimicrobial activity against gram negative bacilli from Yaounde Central Hospital, Cameroon.
2006 · Joseph Gangoue-Pieboji, Sinata Koulla-Shiro, et al. · African Health Sciences · 43
PDF
Works count: 139
Citation count: 3,277
H-index: 35
I10-index: 71
Year
Topic
Type